Brief: Bone Therapeutics H1 Total Operating Income Down At 1.7 Million Euros

Biosenic SA

30/08/2019 06:23

Aug 30 (Reuters) - BONE THERAPEUTICS SA  BOTHE.BR :
    * REG-BONE THERAPEUTICS REPORTS HALF YEAR 2019 RESULTS
    * H1 TOTAL OPERATING INCOME AMOUNTED TO € 1.68 MILLION, A
SLIGHT
DECREASE COMPARED TO THE SAME PERIOD IN 2018 (€ 1.88 MILLION).
    * H1 OPERATING LOSS FOR THE PERIOD AMOUNTED TO € 5.44
MILLION,
COMPARED TO € 6.08 MILLION IN H1 2018.
    * COMPANY ENDED THE FIRST SIX MONTHS OF 2019 WITH € 13.16
MILLION
IN CASH AND CASH EQUIVALENTS
    * CASH USED IN H2 IS EXPECTED TO AMOUNT TO EUR 6-7 MILLION
LARGELY
DRIVEN BY EXTERNAL COSTS ASSOCIATED WITH INCREASED CLINICAL
DEVELOPMENT ACTIVITIES
    * ANTICIPATED NET CASH BURN OF EUR 12-13 MILLION FOR FULL
YEAR
2019
    * THE COMPANY EXPECTS TO HAVE SUFFICIENT LIQUIDITY TO
ACHIEVE ITS
OBJECTIVES UNTIL THE THIRD QUARTER OF 2020

Source text for Eikon:  ID:nGNETbFMf 
Further company coverage:  BOTHE.BR 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))